We are live on ! Find out more
SBBP

Strongbridge Biopharma plc.
SBBP

Delisted

SBBP was delisted on the 5th of October, 2021.

Back to rankings

64 hedge funds and large institutions have $187M invested in Strongbridge Biopharma plc. in 2018 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 12

4% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 25

2% less funds holding

Funds holding: 65 → 64 (-1)

31% less capital invested

Capital invested by funds: $273M → $187M (-$85.6M)

40% less funds holding in top 10

Funds holding in top 10: 5 → 3 (-2)

Holders
64
Holders Change
-1
Holders Change %
-1.54%
% of All Funds
1.46%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
24
Increased
19
Reduced
12
Closed
25
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LSC
Lyon Street Capital
California
+$10.1M
2
SFM
Sphera Funds Management
Israel
+$4.93M
3
Millennium Management
Millennium Management
New York
+$3.84M
4
Goldman Sachs
Goldman Sachs
New York
+$2.62M
5
PWAM
Park West Asset Management
California
+$2.19M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$9.32M
2
AC
Armistice Capital
New York
-$8.88M
3
BC
Broadfin Capital
New York
-$3.32M
4
State Street
State Street
Massachusetts
-$2.61M
5
Northern Trust
Northern Trust
Illinois
-$2.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
51
State Street
Massachusetts
$109K -$2.61M -356,429 -95%
JT
52
Jump Trading
Illinois
$104K +$127K +17,409 New
LCM
53
Laurion Capital Management
New York
$101K +$123K +16,800 New
TRCT
54
Tower Research Capital (TRC)
New York
$96K +$117K +15,996 New
Invesco
55
Invesco
Georgia
$95K -$179K -24,401 -61%
CC
56
Centiva Capital
New York
$95K +$116K +15,865 New
Bank of America
57
Bank of America
North Carolina
$91K +$86.8K +11,859 +356%
OC
58
Oppenheimer & Co
New York
$89K +$9.64K +1,317 +10%
Two Sigma Advisers
59
Two Sigma Advisers
New York
$76K +$92.2K +12,600 New
EMG
60
Ellington Management Group
Connecticut
$73K +$88.5K +12,100 New
AAMU
61
Amundi Asset Management US
Massachusetts
$62K – – –
Manulife (Manufacturers Life Insurance)
62
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$8K -$160K -21,891 -94%
SWM
63
SeaCrest Wealth Management
New York
$5K – – –
Daiwa Securities Group
64
Daiwa Securities Group
Japan
$1K – – –
Northern Trust
65
Northern Trust
Illinois
– -$2.1M -237,053 Closed
ZIM
66
Zacks Investment Management
Illinois
– -$1.54M -173,819 Closed
TCIM
67
TIAA CREF Investment Management
New York
– -$1.14M -129,096 Closed
Vanguard Group
68
Vanguard Group
Pennsylvania
– -$796K -89,978 Closed
EI
69
EAM Investors
California
– -$678K -76,595 Closed
Bank of New York Mellon
70
Bank of New York Mellon
New York
– -$599K -67,671 Closed
Charles Schwab
71
Charles Schwab
California
– -$514K -58,000 Closed
California State Teachers Retirement System (CalSTRS)
72
California State Teachers Retirement System (CalSTRS)
California
– -$378K -42,671 Closed
TA
73
Teachers Advisors
New York
– -$334K -37,782 Closed
Marshall Wace
74
Marshall Wace
United Kingdom
– -$332K -37,500 Closed
New York State Common Retirement Fund
75
New York State Common Retirement Fund
New York
– -$229K -25,900 Closed
1 2
3
4

SBBP Hedge Fund Activity: Q2 2018 in Review

64 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Strongbridge Biopharma plc. (SBBP) for Q2 2018, worth a combined $187M — down 31% from $273M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of SBBP and 24 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 19 added.

The largest buyer was Lyon Street Capital, adding an estimated $10.1M. The largest seller was BlackRock, cutting an estimated $9.32M.

  • 64 institutional investors held Strongbridge Biopharma plc. (SBBP) as of Q2 2018, down from 65 in Q1 2018.
  • Funds reported $187M of Strongbridge Biopharma plc. stock for Q2 2018, down 31% quarter-over-quarter.
  • 24 funds opened new Strongbridge Biopharma plc. positions in Q2 2018 and 25 closed out, a net change of -1 holder.
  • The largest Strongbridge Biopharma plc. buyer in Q2 2018 was Lyon Street Capital, an estimated $10.1M added.
  • The largest Strongbridge Biopharma plc. seller in Q2 2018 was BlackRock, an estimated $9.32M sold.

Based on aggregated 13F filings for Q2 2018.